Prostate cancer therapy linked to Alzheimer's

MEN taking a prostate cancer treatment known as androgen deprivation therapy may be almost twice as likely to develop Alzheimer’s disease as those not taking it, a study has found.

While the research in the 7 December issue of the Journal of Clinical Oncology stops short of showing a definitive cause and effect between ADT and Alzheimer’s, scientists say the association raises concern and merits further study.

“We wanted to contribute to the discussion regarding the relative risks and benefits of ADT, and no one had yet looked at the association between